Skip to Content

Kovanaze Approval History

  • FDA approved: Yes (First approved June 29th, 2016)
  • Brand name: Kovanaze
  • Generic name: oxymetazoline hydrochloride and tetracaine hydrochloride
  • Dosage form: Nasal Spray
  • Company: St. Renatus LLC
  • Treatment for: Local Anesthesia

Kovanaze (oxymetazoline hydrochloride and tetracaine hydrochloride) is a vasoconstrictor and local anesthetic combination administered intranasally as a topical anesthetic for use in restorative dental procedures.

Development History and FDA Approval Process for Kovanaze

Jul 12, 2016Approval St. Renatus, LLC Announces FDA Approval of Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray for Use in Dentistry

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.